Evidence map›Paper›PMID 32558386›Full record

ArticleEMBO molecular medicine2020

PI 3-kinase delta enhances axonal PIP

Bart Nieuwenhuis, Amanda C Barber, Rachel S Evans, Craig S Pearson, Joachim Fuchs, Amy R MacQueen, Susan van Erp, Barbara Haenzi, Lianne A Hulshof, Andrew Osborne and 11 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. A renaissance in targeting the PI3K/AKT/mTOR pathway.Nature reviews. Drug discovery · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Hyperactive delta isoform of PI3 kinase enables long-distance regeneration of adult rat corticospinal tract.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  9. Review
  10. Article
  11. GFRα1 Promotes Axon Regeneration after Peripheral Nerve Injury by Functioning as a Ligand.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Iridoids rich fraction fromFrontiers in molecular neuroscience · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 6 countries.

Bart Nieuwenhuis *John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2065-2271
Amanda C Barber *John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Rachel S Evans *John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Craig S PearsonJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Joachim FuchsInstitute of Biochemistry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Amy R MacQueenLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, UK.
Susan van ErpMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-0883-2795
Barbara HaenziJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Lianne A HulshofJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Andrew OsborneJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Raquel ConceicaoJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Tasneem Z KhatibJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Sarita S DeshpandeJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Joshua CaveJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Charles Ffrench-ConstantMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Patrice D SmithDepartment of Neuroscience, Carleton University, Ottawa, ON, Canada.
Klaus OkkenhaugDepartment of Pathology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9432-4051
Britta J EickholtInstitute of Biochemistry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Keith R MartinJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
James W FawcettJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0002-7990-4568
Richard EvaJohn Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0305-0452
University of Cambridge · GBCharité - Universitätsmedizin Berlin · DEMRC Centre for Regenerative Medicine · GBBabraham Institute · GBCarleton University · CANetherlands Institute for Neuroscience · NLThe University of Melbourne · AU

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
Biotechnology and Biological Sciences Research Council BBS/E/B/000C0409Medical Research Council G0300336Medical Research Council MR/K017047/1Medical Research Council MR/R004463/1Medical Research Council MR/R004544/1NIGMS NIH HHS T32 GM007200Wellcome Trust
6 · The paper itself

Abstract

Peripheral nervous system (PNS) neurons support axon regeneration into adulthood, whereas central nervous system (CNS) neurons lose regenerative ability after development. To better understand this decline whilst aiming to improve regeneration, we focused on phosphoinositide 3-kinase (PI3K) and its product phosphatidylinositol (3,4,5)-trisphosphate (PIP

Indexed as

AxonsPhosphatidylinositol 3-KinasesAdultAnimalsCentral Nervous SystemHumansMiceNerve RegenerationNeuronsRatsPhosphatidylinositol 3-Kinasesaxon transportCNS axon regenerationoptic nervep110 deltaphosphoinositide 3-kinase

Identifiers

PMID32558386
PMCPMC7411663
OpenAlexW3036597754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.